Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial.

Saved in:
Bibliographic Details
Title: Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial.
Authors: Wedemeyer H; Medizinische Hochschule Hannover, Klinik für Gastroenterologie, Hepatologie, Infektiologie und Endokrinologie, Hannover, Germany. Electronic address: Wedemeyer.heiner@mh-hannover.de., Aleman S; Karolinska University Hospital/Karolinska Institute, Department of Infectious Diseases, Stockholm, Sweden., Brunetto M; University Hospital of Pisa, Hepatology Unit, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, Pisa, Italy; University of Pisa, Department of Clinical and Experimental Medicine, Pisa, Italy., Blank A; Heidelberg University Medical Faculty, Heidelberg University Hospital, Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg, Germany., Andreone P; University of Modena and Reggio Emilia, Internal Medicine, Baggiovara Hospital, Modena, Italy., Bogomolov P; State Budgetary Institution of Health Care of Moscow Region, Moscow Regional Research Clinical Institute Named After M.F. Vladimirsky, Moscow, Russian Federation., Chulanov V; FSBI National Research Medical Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation, Moscow, Russian Federation., Mamonova N; FSBI National Research Medical Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation, Moscow, Russian Federation., Geyvandova N; Stavropol Regional Hospital, Stavropol, Russian Federation., Morozov V; Hepatolog, LLC, Samara, Russian Federation., Sagalova O; Federal State-Funded Institution of Higher Education, South Ural State Medical University of Ministry of Health of the Russian Federation, Chelyabinsk, Russian Federation., Stepanova T; Clinic of Modern Medicine, Moscow, Russian Federation., Berger A; Institute for Medical Virology, German Centre for Infection Research, External Partner Site Frankfurt, University Hospital, Goethe University, Frankfurt am Main, Germany., Ciesek S; Institute for Medical Virology, German Centre for Infection Research, External Partner Site Frankfurt, University Hospital, Goethe University, Frankfurt am Main, Germany., Manuilov D; Gilead Sciences, Foster City, CA, United States., Mercier RC; Gilead Sciences, Foster City, CA, United States., Da BL; Gilead Sciences, Foster City, CA, United States., Chee GM; Gilead Sciences, Foster City, CA, United States., Li M; Gilead Sciences, Foster City, CA, United States., Flaherty JF; Gilead Sciences, Foster City, CA, United States., Lau AH; Gilead Sciences, Foster City, CA, United States., Osinusi A; Gilead Sciences, Foster City, CA, United States., Schulze Zur Wiesch J; Universitätsklinikum Hamburg-Eppendorf, Medizinische Klinik Studienambulanz Hepatologie, Hamburg, Germany., Cornberg M; Medizinische Hochschule Hannover, Klinik für Gastroenterologie, Hepatologie, Infektiologie und Endokrinologie, Hannover, Germany., Zeuzem S; University Hospital Frankfurt, Department of Medicine, Frankfurt am Main, Germany., Lampertico P; Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; CRC A. M. and A. Migliavacca Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Source: Journal of hepatology [J Hepatol] 2024 Oct; Vol. 81 (4), pp. 621-629. Date of Electronic Publication: 2024 May 09.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1600-0641
DOI:10.1016/j.jhep.2024.05.001